Şunu aradınız:: dijanjostikati (Maltaca - İngilizce)

monoterapija (pazjenti li għadhom kemm ġew dijanjostikati)
monotherapy (newly diagnosed patients)

pazjenti li jkunu għadhom kif ġew dijanjostikati bi glioblastoma multiforme
patients with newly-diagnosed glioblastoma multiforme

il-pazjenti li jieħdu zerit għandhom jiġu dijanjostikati spiss.
patients taking zerit should be assessed frequently.

pazjenti adulti li jkunu għadhom kif ġew dijanjostikati bi glioblastoma multiforme
adult patients with newly-diagnosed glioblastoma multiforme

pazjenti adulti li jkunu għadhom kif ġew dijanjostikati b’ glioblastoma multiforme
adult patients with newly -diagnosed glioblastoma multiforme

pazjenti li jkunu għadhom kif ġew dijanjostikati b’i glijoblastoma multiforme:
patients with newly-diagnosed glioblastoma multiforme:

provi kliniċi f’ ph+ all ph+ all li jkunu għadhom kif ġew dijanjostikati:
clinical studies in ph+ all newly diagnosed ph+ all:

meta daħlu fl-istudju l-pazjenti kienu ilhom dijanjostikati b’itp għal madwar 8 snin .
patients had been diagnosed with itp for approximately 8 years at the time of study entry.

għad hemm numru kbir ta’ persuni bl-hiv/aids fl-ewropa li għadhom ma ġewx dijanjostikati.
there are still large numbers of people living with hiv/aids (plwha) in europe who have not yet been diagnosed.

għalxiex jintuża revlimid revlimid flimkien ma ’ dexamethasone jintuża biex jikkura pazjenti adulti li kienu dijanjostikati b’ mjeloma multipla.
what revlimid is used for revlimid in combination with dexamethasone is used to treat adult patients who have been diagnosed with multiple myeloma.

il-pazjenti kollha kienu dijanjostikati li kellhom nsclc fi stadju iiib jew iv u li diġà kienu rċevew kimoterapija bbażata fuq il-platinu.
all patients were diagnosed with stage iiib or iv nsclc and had received prior platinum-based chemotherapy.

episodji li joħorġu wara l-kura matul fażijiet ta’ kura konkomittanti u monoterapija f’pazjenti li jkunu għadhom kif ġew dijanjostikati bi glioblastoma multiforme
table 4.treatment-emergent events during concomitant and monotherapy treatment phases in patients with newly-diagnosed glioblastoma multiforme

adulti li ġew dijanjostikati għall-ewwel darba bi glijoblastoma multiforme (tip aggressiv ta’ tumur tal-moħħ).
adults with newly diagnosed glioblastoma multiforme (an aggressive type of brain tumour).

dan jintuża fi tfal li jkunu għadhom kif ġew dijanjostikati bil-ph+ cml u li mhumiex eliġibbli għal trapjant tal- mudullun tal-għadam.
it is used in children who have been newly diagnosed with ph+ cml and who are not eligible for a bone marrow transplant.

huwa rrakkomandat li l-kura b’trastuzumab emtansine titwaqqaf għalkollox f’pazjenti li jiġu dijanjostikati b’ild jew b’pulmonite.
it is recommended that treatment with trastuzumab emtansine be permanently discontinued in patients who are diagnosed with ild or pneumonitis.

il- maġġoranza tal-każijiet ta’ pml ġew dijanjostikati fi żmien 12-il xahar tal-ewwel doża tagħhom ta’ velcade.
most cases of pml were diagnosed within 12 months of their first dose of velcade.

l-aktar żewġ kundizzjonijiet dijanjostikati ta’ spiss waqt il-kura b’raloxifene, assoċjati mat-tnixxija ta’ demm mill- utru, kienu l-atrofija ta’ l-endometriju u l-qarnit beninju ta’ l-endometriju.
the two most frequent diagnoses associated with uterine bleeding during raloxifene treatment were endometrial atrophy and benign endometrial polyps.